4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Myotonic dystrophy is an inherited systemic disorder affecting skeletal muscle and the heart.
Genetic testing for myotonic dystrophy is diagnostic and identifies those at risk for cardiac …

Myotonic dystrophy (DM) is a multi‐systemic disease that impacts cardiac and skeletal
muscle as well as the central nervous system (CNS). DM is unusual because it is an RNA …

Cardiac dysfunction is a prominent cause of mortality in myotonic dystrophy I (DM1), a
disease where expanded CUG repeats bind and disable the muscleblind-like family of …

Myotonic dystrophy (MD) is a multisystem, autosomal dominant disorder best known for its
skeletal muscle manifestations. Cardiac manifestations arise as a result of myocardial fatty …

Background—Myotonic dystrophy type 2 (DM2) is a genetic disorder characterized by
skeletal muscle symptoms, metabolic changes, and cardiac involvement. Histopathologic …

In this review, we describe using examples the recent advances in the genetic diagnosis of
neuromuscular disorders, in research and clinical practice and the latest developments that …

Background Myotonic dystrophy type 1 (DM1) is associated with increased cardiac morbidity
and mortality. Therefore, assessment of cardiac involvement and risk stratification for sudden …

Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults and
children, is a multi-systemic disorder affecting skeletal, cardiac, and smooth muscles as well …

Objective Cardiac disease accounts for a large burden of premature mortality and morbidity
in patients with type 1 myotonic dystrophy (MD). However, little is known about structural …